$13.58

-0.14 (-1.02%)

Pre-Market: $13.65 (+0.07, +0.52%)

Weekly Expected Move ±1.3%

$14 $14 $14 $14 $14

NASDAQ · Healthcare · Medical - Devices · Tech Score Sell · Power 33 · $781.4M mcap · 48M float · 1.18% daily turnover · Short 42% of daily vol

Credit Risk of going bust: lower than 95% of companies Debt: 0.6% of company value Bonds: none of note held by US funds details ▾

If the stock fell to about $0.01 (down more than 99.9%), InMode Ltd. would be worth roughly what it owes.
Total debt $4.5M against a stock market value of $781.4M.
Distance to default 19.72 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $2.2M (short-term plus half of long-term), stock volatility 29.8%; Altman Z'' 13.22. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.

Overview Chart Smart Money Financials Income Statement Cash Flow Balance Sheet Earnings

Analysis Technicals Weather Peers ESG Institutions ETF Exposure Dark Pool Short Interest

Revenue Segmentation

By Product / Service

By Geography

Revenue by Segment (5-Year Trend)

Income Trends

Revenue

$370M -6.2% ▼

5Y CAGR: +12.4%

Gross Profit

$291M -8.2% ▼

5Y CAGR: +10.7%

Operating Income

$85M -24.1% ▼

5Y CAGR: +3.2%

Net Income

$94M -48.2% ▼

5Y CAGR: +4.6%

EPS (Diluted)

$1.43 -36.4% ▼

5Y CAGR: +9.9%

EBITDA

$111M -2.0% ▼

5Y CAGR: +8.7%

Profit Margins

Year-over-Year Growth

View Full Income Statement

Line Item	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	$358M	$454M	$492M	$395M	$370M
YoY Growth	+73.5%	+27.0%	+8.3%	-19.8%	-6.2%
Cost of Revenue	$54M	$73M	$81M	$78M	$80M
Gross Profit	$304M	$381M	$411M	$317M	$291M
Gross Margin	85.0%	83.8%	83.6%	80.3%	78.5%
R&D Expenses	$10M	$12M	$13M	$13M	$13M
SG&A Expenses	$128M	$171M	$202M	$191M	$192M
Operating Expenses	$136M	$183M	$216M	$205M	$206M
Operating Income	$167M	$198M	$196M	$113M	$85M
Operating Margin	46.8%	43.6%	39.8%	28.5%	23.0%
Interest Expense	$0	$0	$0	$0	$0
Income Before Tax	$168M	$201M	$217M	$143M	$110M
Tax Expense	$3M	$40M	$19M	-$38M	$16M
Net Income	$165M	$162M	$198M	$181M	$94M
Net Margin	46.1%	35.6%	40.2%	45.9%	25.3%
EPS (Diluted)	$1.92	$1.89	$2.30	$2.25	$1.43
EBITDA	$168M	$199M	$196M	$113M	$111M
Shares Outstanding	86M	85M	86M	81M	65M

Line Item	FY2024 Q3	FY2024 Q4	FY2025 Q1	FY2025 Q2	FY2025 Q3	FY2025 Q4	FY2026 Q1	FY2026 Q2
Revenue	$130M	$98M	$78M	$96M	$93M	$104M	$82M	$96M
Cost of Revenue	$24M	$20M	$17M	$19M	$21M	$23M	$20M	$24M
Gross Profit	$106M	$78M	$61M	$76M	$72M	$81M	$62M	$72M
Gross Margin	81.5%	79.3%	78.2%	80.0%	77.6%	78.3%	75.0%	74.8%
R&D Expenses	$3M	$3M	$3M	$3M	$4M	$4M	$4M	$4M
SG&A Expenses	$55M	$47M	$42M	$50M	$48M	$52M	$48M	$56M
Operating Expenses	$58M	$50M	$45M	$54M	$51M	$55M	$51M	$59M
Operating Income	$48M	$28M	$16M	$23M	$21M	$26M	$10M	$12M
Operating Margin	37.1%	28.5%	20.1%	23.9%	22.4%	25.0%	12.3%	12.8%
Interest Expense	$0	$0	$0	$0	$0	$0	$0	$0
Income Before Tax	$58M	$32M	$22M	$31M	$26M	$31M	$14M	$20M
Tax Expense	$7M	-$51M	$4M	$4M	$4M	$4M	$3M	$3M
Net Income	$51M	$83M	$18M	$27M	$22M	$27M	$12M	$17M
Net Margin	39.2%	84.6%	23.4%	28.0%	23.5%	26.0%	14.1%	17.9%
EPS (Diluted)	$0.65	$1.14	$0.26	$0.42	$0.34	$0.42	$0.18	$0.29
EBITDA	$48M	$28M	$16M	$31M	$26M	$31M	$15M	$12M
Shares Outstanding	79M	73M	69M	64M	64M	64M	64M	59M

INMD NASDAQ